腫瘍の発達と進行におけるがん関連フィブロブラストの代謝再プログラミングの役割 (レビュー)

Ruyue Li¹, Yintao Li²

¹School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong 261053, P.R. China.

International journal of oncology

|August 29, 2025

まとめ

癌に関連した線維細胞 (CAF) は,腫瘍の成長と進行を刺激するために,その代謝を再プログラムします. CAFの代謝経路をターゲットにすることで癌の治療と薬剤耐性を克服する新しい治療戦略が生まれます

科学分野:

腫瘍学
癌生物学
代謝経路

背景:

腫瘍の発達には,腫瘍細胞と腫瘍の微小環境 (TME) が影響する.
癌に関連した線維芽細胞 (CAF) は,TME内の重要な構造細胞であり,様々な細胞タイプから発生します.
CAFはTMEを調節し,腫瘍の進行に影響を及ぼします.

研究の目的:

癌に関連した線維細胞 (CAF) の代謝再プログラミングの役割を検討する.
CAFの代謝変化が腫瘍の発達と進行にどのように影響するかを強調する.
治療戦略開発におけるCAFの異質性と可塑性の重要性を強調する.

主な方法:

CAFの代謝に関する既存の研究を要約した文献レビュー.
CAFの代謝再プログラムが腫瘍に与える機能的影響に関する研究の分析
TMEにおけるCAFの異質性と可塑性に関する発見のまとめ

主要な成果:

CAFの代謝再プログラミングは,TME低酸素と栄養素不足によって引き起こされるエネルギー不足を相殺することができます.
変化したCAFの代謝パターンは,腫瘍細胞の増殖,移動,侵入,転移に影響する.
CAFは,代謝適応を通して腫瘍の薬剤耐性を促進する.

結論:

CAFの代謝再プログラムが腫瘍の進行における重要な要因である.
CAFの異質性と可塑性を理解することは効果的ながん治療に不可欠です.
CAFの特定の代謝経路をターゲットにすることで,がん治療の有効性を向上させ,薬剤耐性を克服することができます.

キーワード:

アミノ酸癌に関連した線維芽細胞グリコリス脂質代謝の再プログラム腫瘍

さらに関連する動画

06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

4.6K

15:43

Experimental Generation of Carcinoma-Associated Fibroblasts CAFs from Human Mammary Fibroblasts

Published on: October 25, 2011

23.5K

関連する概念動画

02:17

The Tumor Microenvironment

6.8K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

6.8K

03:03

mTOR Signaling and Cancer Progression

3.9K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

3.9K

02:53

Adaptive Mechanisms in Cancer Cells

5.9K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

5.9K

02:07

Tumor Progression

6.5K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

6.5K

01:09

Introduction to Fibroblasts

3.2K

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...

3.2K

02:40

Cancer Stem Cells and Tumor Maintenance

5.0K

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...